Related Experiment Videos
[Antioncogenes: models for tumors in children]
C Junien1, I Henry, C Jeanpierre
1INSERM U73, Château-de-Longchamp, Paris, France.
Bulletin Du Cancer
|January 1, 1991
Summary
Genetic mapping of cancer susceptibility genes is possible through chromosomal abnormalities and family studies. Tumor-specific rearrangements indicate suppressor genes or genetic heterogeneity, potentially involving genomic imprinting.
Area of Science:
- Human Genetics
- Cancer Genetics
- Molecular Biology
Context:
- Understanding the genetic basis of hereditary cancer syndromes and tumor development is crucial.
- Chromosomal abnormalities and family studies are key tools for gene mapping.
- Somatic rearrangements in tumors provide insights into genetic drivers of cancer.
Purpose:
- To elucidate the chromosomal location of genes predisposing individuals to malignancy.
- To investigate the role of chromosomal rearrangements in tumor progression and genetic heterogeneity.
- To explore the involvement of genomic imprinting in cancer development.
Summary:
- Genes conferring susceptibility to malignancy and malformation syndromes can be mapped using constitutional chromosomal abnormalities or family linkage studies.
- Somatic chromosomal rearrangements at specific loci in tumors suggest the presence of recessive tumor suppressor genes (antioncogènes).
- Rearrangements in different chromosomal regions for other tumors imply genetic heterogeneity and genes involved in tumor progression, which may be subject to differential genomic imprinting.
Impact:
- This research aids in identifying genes responsible for hereditary cancer syndromes, improving risk assessment and genetic counseling.
- Understanding the genetic underpinnings of tumor progression can lead to novel therapeutic strategies.
- The findings contribute to the broader knowledge of gene regulation, including genomic imprinting, in development and disease.